FindTrial
Sign In

Survey Study on Ayurvedic Practitioners Perceptions and Practices in Prescribing Schedule E Drugs ( Poisonous drugs ) in Maharashtra

Exploring the Perceptions and Practices of Ayurvedic Practitioners Regarding Prescription of Schedule E Drugs in Maharashtra A Survey Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/070968
Enrollment
100
Registered
2024-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Vaishnav Madhukarrao Kale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Ayurvedic Practioner registered under M.C.I.M - Maharashtra Council Of Indian Medicine ( BAMS GRADUATED )

Exclusion criteria

Exclusion criteria: Those who are not registered under M. C. I. M. - Maharashtra Council of Indian Medicine

Design outcomes

Primary

MeasureTime frame
The study seeks to shed light on the awareness levels in relation to Schedule E drugsTimepoint: 6 Months—

Secondary

MeasureTime frame
To gather insights into the challenges faced by Ayurvedic practitioners in prescribing Schedule E drugs & their suggestions for improvement.Timepoint: 6 months—

Countries

India

Contacts

Public ContactDr Abhijeet Shirkande

Dr D Y Patil College of Ayurved and Research Centre Pimpri Pune

drabhijitshirkande@gmail.com9975253664

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026